Drugs / CD34(+) cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00221143 | Nov 2003 → Jan 2008 | limb ischemia, peripheral vascular disease, ulcer disease | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | Completed | Met primary |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD34(+) cells | “CD34(+) cells were isolated from the G-CSF-mobilized apheresis product using a magnetic cell sorting system.” PMID 19711453 ↗ Nov 2009 |
| Known as | CD34 positive cells | “autologous peripheral blood endothelial progenitor cells (CD34 positive cells)” NCT00221143 ↗ |
| Modality | Cell therapy | “CD34+ cell therapy” PMID 22877866 ↗ Jul 2012 |
| Route | Intramuscular | “intramuscular transplantation of granulocyte colony stimulating factor-mobilized CD34 positive cells” PMID 22877866 ↗ Jul 2012 |